Analysis of Immune Checkpoint Inhibitor Efficacy in Mesothelioma Immune checkpoint inhibitors have changed treatment approaches for several cancers. Researchers now examine their effectiveness in mesothelioma. Studies stratify results by PD-L1 expression and histological subtype. This analysis helps identify which patients benefit most. PD-L1 expression serves as a key biomarker. Higher PD-L1 levels often correlate with […]
Category: Medicine
In this article we will discuss Cytoreductive Surgery and HIPEC in Peritoneal Malignancies
In this article we will discuss Oncogenic Signaling Pathways: PI3K/AKT/mTOR
In this article we will discuss Analytical and clinical validation of liquid biopsy assays for minimal residual disease detection after curative treatment
Clinical practice guidelines shape oncology care worldwide. Major organizations such as NCCN, ASCO, and ESMO publish these documents regularly. Clinicians rely on them for diagnosis, treatment, and follow-up decisions. However, the quality of evidence that supports these recommendations varies. Therefore, systematic assessment becomes essential. Researchers apply two key tools for this purpose. AGREE II evaluates […]
Central line-associated bloodstream infections remain a serious risk in hospitals. These infections increase patient suffering, length of stay, and healthcare costs. Effective prevention strategies therefore receive high priority. Care bundles form the core of most prevention programmes. A bundle combines several evidence-based practices into one structured set. When staff apply all elements together, the protective […]